MEET OUR

2024

SPEAKERS

"Gene therapy using AAV viral vectors ; from vector engineering to preclinical evaluation"

Unité : U 1089 / TaRGet

Ville : Nantes

"The missions of the Health Innovation Agency"

"Therapeutic oligonucleotides: efficient and specific tools to combat diseases"

Unité : U 1212 / UMR 5320 / ARNA : Acides Nucléiques : Régulations Naturelle et Artificielle 

Ville : Bordeaux

"How to secure CRISPR-Cas9 use ?"

Unité : U 1312 / BRIC - Institut d'oncologie de Bordeaux

Ville : Bordeaux 

 "Pioneering Genomics to Save Sight"

"Programming bacteria as smart therapeutics"

Unité : U 1054 / 5048 / CBS

Ville : Montpellier

"Next generation AAV vectors for gene therapy of muscle disorders"

Unité : U 951 / INTEGRARE

Ville : Evry

"MSC-based ATMP: present and future"

Unité : U 1301 / UMR 5070 / RESTORE

Ville : Toulouse

 "Unlocking cell therapy for all"

"Manipulation of tertiary lymphoid structures as the third generation of immunotherapy"

Unité : U 1135

Ville : Paris

"Predicting efficacy and toxicity of CAR T cells using an ex vivo human model"

Unité  : U 1016 / Institut Cochin

Ville : Paris

"Specific Targeting of Cancer Cells by Lentiviral Vectors"

Unité  : FR1589 / IBMC Institut de Biologie cellulaire et molécualaire

Ville : Strasbourg

"Targeting CNS with AAV in a large animal"

"Next generation cell therapies for osteoarticular diseases"

Unité  : U 1183 / Régénération tissulaire, Cellules souches, plasticité cellulaire et immunothérapies des maladies inflammatoires 

Ville : Montpellier

"National research program in biotherapies and bioproduction"

Unité  : UMR0496 / Département Médicaments et Technologies pour la Santé (DMTS)

Ville : Paris-Saclay

"Lakhesys, the microfluidics powered benchtop factory for cell & gene therapies to develop better products and solve scalability"

"Extracellular Vesicle-based vector for targeted therapeutics delivery"

Unité  : U 7057 / MSC / ERL Inserm

Ville : Paris

"A new class of tumor targets for next generation cancer immunotherapies" 

"PEPR Biotherapies and Bioproduction of innovative therapies"

Unité  : U 861 / I-STEM

Ville : Evry

"Cell Therapy of Heart Failure : Cells, Exosomes, RNAs"

Unité  : U 970 / Paris - Centre De Recherche Cardiovasculaire

Ville : Paris

"Genome editing approaches for beta-hemoglobinopathies"

Unité  : U 1163 / Institut IMAGINE

Ville : Paris

"Production of lipid nanoparticles formulations for gene and cell therapy"

Unité : U 1267 / UMR 8258 / UTCBS

Villes : Paris

"A stem cell therapy pipeline with focus on retinitis pigmentosa and other rare indications with high unmet medical needs"

"The game changing potential of mRNA-based vaccines and therapeutics"

Unité  : US 55 Inserm / UPR 4301 CNRS / ART "Technologies ARN Messager", CBM : Département Biologie cellulaire, Cibles pharmacologiques et Thérapies innovantes 

Ville : Orléans

"An Open-label, Multicenter, Phase 1/2 Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323, a CAR-T Cell Therapy Targeting CD19 for Severe Refractory SLE (Preliminary Results)"

"Optimizing Adoptive Cellular Therapies in Physio-Chemical Tumor Environments for Superior Anti-Cancer Efficacy without systemic toxicity"

Unité  : U 1277 / Hétérogénéité, plasticité et résistance des cancers aux thérapies

Ville : Lille

"From Innovation to Industrialization: Challenges in Research and Development of mRNA Vaccines"